|Post IPO Valuation|
|Description||Global Healthcare Products Leader|
|Maya Medical, 5/12|
|BARRX Medical, 11/11||$325M|
|Aspect Medical Systems, 12/09||$58M|
Covidien plc engages in the development, manufacture, and sale of healthcare products for use in clinical and home settings. Segments The company operates its businesses through four segments:
Medical Devices includes the development, manufacture and sale of endomechanical instruments, soft tissue repair products, energy devices, oximetry and monitoring products, airway and ventilation products, vascular devices, SharpSafety products, clinical care products and other medical device products;
Imaging Solutions includes the development, manufacture and marketing of radiopharmaceuticals and contrast products;
Pharmaceutical Products includes the development, manufacture and distribution of dosage pharmaceuticals and active pharmaceutical ingredients; and Medical Supplies includes the development, manufacture and sale of nursing care products, medical surgical products and original equipment manufacturer products (OEM).
The Medical Device segment develops, manufactures and sells an array of products which the company categorizes in the following product groups:
Endomechanical Instrumentsâ€”includes its laparoscopic instruments and surgical staplers.
Soft Tissue Repair Productsâ€”includes its sutures, mesh and biosurgery products.